In: Guidance on Pre-Exposure Oral Prophylaxis (PrEP) for Serodiscordant Couples, Men and Transgender Women Who Have Sex with Men at High Risk of HIV: Recommendations for Use in the Context of Demonstration Projects. edn. Geneva; 2012.
Smith DK, Grant RM, Weidle PJ, Lansky A, Fenton KAJJTJotAMA: Interim guidance: Preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. 2011;305(11):1089–91.
Xinyu Y. Practice and challenges of HIV pre-exposure prophylaxis and post-exposure prophylaxis. Chi J AIDS STD. 2019;25(4):425–8.
Google Scholar
In: Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. edn. Geneva; 2015.
Aschenbrenner DS. Descovy approved for HIV Prexposure prophylaxis. Am J Nurs. 2020;120(2):20–1. https://doi.org/10.1097/01.NAJ.0000654292.06762.bd.
Article
PubMed
Google Scholar
Hoornenborg E, Krakower DS, Prins M, Mayer KH. Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries. Aids. 2017;31(16):2179–91. https://doi.org/10.1097/QAD.0000000000001627.
Article
PubMed
Google Scholar
Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the international AIDS society-USA panel. JAMA. 2010;304(3):321–33. https://doi.org/10.1001/jama.2010.1004.
Article
CAS
PubMed
Google Scholar
Rhee SY, Kantor R, Katzenstein DA, Camacho R, Morris L, Sirivichayakul S, et al. HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes. AIDS. 2006;20(5):643–51. https://doi.org/10.1097/01.aids.0000216363.36786.2b.
Article
PubMed
Google Scholar
Gibas KM, van den Berg P, Powell VE, Krakower DS. Drug resistance during HIV pre-exposure prophylaxis. Drugs. 2019;79(6):609–19. https://doi.org/10.1007/s40265-019-01108-x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fogel JM, Sivay MV, Cummings V, Wilson EA, Hart S, Gamble T, et al. HIV drug resistance in a cohort of HIV-infected MSM in the United States. Aids. 2020;34(1):91–101. https://doi.org/10.1097/QAD.0000000000002394.
Article
CAS
PubMed
Google Scholar
World Health Organization. HIV drug resistance report. 2019. [R/OL]. https://www.who.int/hiv/pub/drugresistance/hivdr-report-2019/en/. Accessed 15 Dec 2019.
Zuo L, Liu K, Liu H, Hu Y, Zhang Z, Qin J, et al. Trend of HIV-1 drug resistance in China: A systematic review and meta-analysis of data accumulated over 17 years (2001-2017). EClinicalMedicine. 2020;18:100238. https://doi.org/10.1016/j.eclinm.2019.100238.
Article
PubMed
PubMed Central
Google Scholar
Zhao B, Han X, Dai D, Liu J, Ding H, Xu J, et al. New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China. AIDS Res Hum Retrovir. 2011;27(10):1047–53. https://doi.org/10.1089/aid.2010.0119.
Article
CAS
PubMed
Google Scholar
Han X, Dai D, Zhao B, Liu J, Ding H, Zhang M, et al. Genetic and epidemiologic characterization of HIV-1 infection in Liaoning Province, China. J Acquir Immune Defic Syndr. 2010;53(Suppl 1):S27–33. https://doi.org/10.1097/QAI.0b013e3181c7d5bf.
Article
PubMed
Google Scholar
Han X, An M, Zhang M, Zhao B, Wu H, Liang S, et al. Identification of 3 distinct HIV-1 founding strains responsible for expanding epidemic among men who have sex with men in 9 Chinese cities. J Acquir Immune Defic Syndr. 2013;64(1):16–24. https://doi.org/10.1097/QAI.0b013e3182932210.
Article
PubMed
PubMed Central
Google Scholar
An M, Han X, Xu J, Chu Z, Jia M, Wu H, et al. Reconstituting the epidemic history of HIV strain CRF01_AE among men who have sex with men (MSM) in Liaoning, northeastern China: implications for the expanding epidemic among MSM in China. J Virol. 2012;86(22):12402–6. https://doi.org/10.1128/JVI.00262-12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhao B, Han X, Xu J, Hu Q, Chu Z, Zhang J, et al. Increase of RT-related transmitted drug resistance in non-CRF01_AE among HIV type 1-infected men who have sex with men in the 7 cities of China. J Acquir Immune Defic Syndr. 2015;68(3):250–5. https://doi.org/10.1097/QAI.0000000000000467.
Article
CAS
PubMed
Google Scholar
NCAIDS, NCSTD, CDC C. Update on the AIDS/STD epidemic in China and main response in control and prevention in October, 2017. Chin J AIDS STD. 2018;24(2):111.
Google Scholar
Wang H, Zhang Y, Mei Z, Jia Y, Leuba SI, Zhang J, et al. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP). BMC Infect Dis. 2019;19(1):721. https://doi.org/10.1186/s12879-019-4355-y.
Article
PubMed
PubMed Central
Google Scholar
Price MN, Dehal PS, Arkin AP. FastTree 2--approximately maximum-likelihood trees for large alignments. PLoS One. 2010;5(3):e9490.
Article
Google Scholar
Maxim Biomedical. Maxim HIV-1 Limiting Antigen Avidity EIA: Single Well Avidity Enzyme Immunoassay for Detection of Recent HIV-1 Infection, Cat. No. 92001; 2013. Available from: http://www.maximbio.com/img/insert/920013-Product-Insert.pdf.
Google Scholar
Granich R, Gupta S, Suthar AB, Smyth C, Hoos D, Vitoria M, et al. Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. Curr HIV Res. 2011;9(6):446–69. https://doi.org/10.2174/157016211798038597.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang FJ, Pan J, Yu L, Wen Y, Zhao Y. Current progress of China's free ART program. Cell Res. 2005;15(11–12):877–82. https://doi.org/10.1038/sj.cr.7290362.
Article
PubMed
Google Scholar
Chinese Medical A, Chinese Center for Disease C, Prevention. Guidelines for diagnosis and treatment of HIV/AIDS in China (2005). Chin Med J. 2006;119(19):1589–608.
Article
Google Scholar
Association APGSoIDCM. Guidelines for diagnosis and treatment of HIV/AIDS in China (2011). Chin J Infect Dis. 2011;29(10):629–40.
Google Scholar
BY W, MM L, XJ B. 958,000 survivors were reported in China, and the AIDS epidemic is at a low level. 2019. http://www.xinhuanet.com/politics/2019-12/01/c_1125295336.htm.
Google Scholar
National Health Commission of the People's Republic of China: Regular press conference: Progress in the prevention and treatment of AIDS in China. http://ncaids.chinacdc.cn/xxgx/yqxx/201811/t20181123_197488.htm. Accessed 19 Oct 2019.
Liu TF, Shafer RW. Web resources for HIV type 1 genotypic-resistance test interpretation. Clin Infect Dis. 2006;42(11):1608–18. https://doi.org/10.1086/503914.
Article
CAS
PubMed
Google Scholar
Press NfAatmctBPsH. National free AIDS antiviral treatment manual [M]; 2005. p. 12–1.
Google Scholar
Cong ME, Mitchell J, Sweeney E, Bachman S, Hanson DL, Heneine W, et al. Prophylactic efficacy of oral emtricitabine and tenofovir disoproxil fumarate combination therapy against a tenofovir-resistant simian/human immunodeficiency virus containing the K65R mutation in macaques. J Infect Dis. 2013;208(3):463–7. https://doi.org/10.1093/infdis/jit189.
Article
CAS
PubMed
PubMed Central
Google Scholar
Powell VE, Gibas KM, DuBow J, Krakower DS. Update on HIV Preexposure prophylaxis: effectiveness, drug resistance, and risk compensation. Curr Infect Dis Rep. 2019;21(8):28. https://doi.org/10.1007/s11908-019-0685-6.
Article
PubMed
Google Scholar